Fiercepharma.comNews Analysis

1

Fresenius Kabi and Phlow Corp. Announce First-Ever, End-to-End, U.S. Manufacturing Collaboration for Epinephri

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

2

Hims retreats from weight loss pill launch as Novo, FDA pressure mounts

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

3

Bayer and celebrity chef keep diners in the dark to shed light on heart health

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

4

Community oncology’s growing role in the future of cancer care

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

5

CSL's bleak earnings report helps explain why it made CEO switch

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

6

Alnylam turns profitable even as Amvuttra ATTR revenue disappoints in Q4

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

7

As Jakafi approaches generic competition, Incyte counts more on Opzelura

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

8

China indicts AstraZeneca and former exec Leon Wang over data, trade charges

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

9

FDA untitled letters target Novo’s 1st Wegovy pill ad and spots from argenx, Sobi

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

10

With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

11

Astellas casts retina specialists as ‘Partners in Protection’ in Izervay HCP campaign

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

12

Novartis to seek full FDA approval for IgAN drug Vanrafia despite missing ph. 3 kidney function goal

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

13

AbbVie mounts fresh IRA legal challenge over Botox's inclusion in latest drug pricing negotiations list

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

14

NIH stops Xarelto arm of stroke trial due to safety, lack of efficacy

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

15

Merck pushes Keytruda across the FDA finish line for its first ovarian cancer nod

Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines...

Fiercepharma.com News

Trending Stories

Fresenius Kabi and Phlow Corp. Announce First-Ever, End-to-End, U.S. Manufacturing Collaboration for Epinephri

Hims retreats from weight loss pill launch as Novo, FDA pressure mounts

Bayer and celebrity chef keep diners in the dark to shed light on heart health

Community oncology’s growing role in the future of cancer care

CSL's bleak earnings report helps explain why it made CEO switch

Alnylam turns profitable even as Amvuttra ATTR revenue disappoints in Q4

As Jakafi approaches generic competition, Incyte counts more on Opzelura

China indicts AstraZeneca and former exec Leon Wang over data, trade charges

FDA untitled letters target Novo’s 1st Wegovy pill ad and spots from argenx, Sobi

With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment

Astellas casts retina specialists as ‘Partners in Protection’ in Izervay HCP campaign

Novartis to seek full FDA approval for IgAN drug Vanrafia despite missing ph. 3 kidney function goal

AbbVie mounts fresh IRA legal challenge over Botox's inclusion in latest drug pricing negotiations list

NIH stops Xarelto arm of stroke trial due to safety, lack of efficacy

Merck pushes Keytruda across the FDA finish line for its first ovarian cancer nod

Trending People

News Stories Published Over Time

Trending Topics

Most Popular Categories

Similar Websites

More Websites